MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10120-019-00930-2

Медицинская библиотека · Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2019

Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.

Takayoshi Kotoe, Kusaba Hitoshi, Aikawa Tomomi, Koreishi Sakuya, Sagara Kosuke, Nakano Michitaka, Komoda Masato, Kono Mihoko, Fukata Mitsuhiro, Arita Takeshi, Esaki Taito, Akashi Koichi, Baba Eishi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Venous thromboembolism (VTE) is highly associated with advanced gastric cancer (AGC) and is sometimes lethal. Predictors of VTE have not been identified, and the efficacy and safety of direct oral anticoagulants (DOACs) for AGC-associated VTE remain to be clarified.

METHODS

A total of 188 AGC patients who started chemotherapy during the period from January 2014 to December 2017 in our institutions were retrospectively examined for the incidence of VTE, risk factors for VTE, and the efficacy and safety of DOAC-based anticoagulant therapy for VTE.

RESULTS

Thirty-four patients (18%) were diagnosed with VTE at the start or during the course of chemotherapy (VTE group). More VTE group patients had a history of abdominal surgery and had moderate-severe ascites (32% versus 17%, 32% versus 14%, respectively) than non-VTE group patients (NVTE group). The mean serum albumin concentrations in the VTE group were significantly lower than NVTE group (3.38 mg/dL vs 3.65 mg/dL, respectively). Multivariate analysis showed that hypoalbuminemia was significantly correlated with VTE (P = 0.012). In the VTE group, 29 patients (85%) received anticoagulant therapy, including 24 patients treated with DOACs. No lethal VTE was observed in any patients. Thirteen patients (45%) terminated DOACs because of anemia or bleeding events, of whom eleven developed major bleeding. Median overall survivals of the VTE and NVTE groups were 9.63 months and 11.5 months, respectively (P = 0.262).

CONCLUSION

Hypoalbuminemia appears to be a risk factor for AGC-associated VTE. DOACs are effective to AGC-associated VTE, but careful observation of bleeding events is required.

Для цитирования: Takayoshi Kotoe, Kusaba Hitoshi, Aikawa Tomomi, Koreishi Sakuya, Sagara Kosuke, Nakano Michitaka, Komoda Masato, Kono Mihoko, Fukata Mitsuhiro, Arita Takeshi, Esaki Taito, Akashi Koichi, Baba Eishi. Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2019. DOI: 10.1007/s10120-019-00930-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.